Broad and potent neutralization of HIV-1 by a gp41-specific human antibody

J Huang, G Ofek, L Laub, MK Louder, NA Doria-Rose… - Nature, 2012 - nature.com
J Huang, G Ofek, L Laub, MK Louder, NA Doria-Rose, NS Longo, H Imamichi, RT Bailer…
Nature, 2012nature.com
Abstract Characterization of human monoclonal antibodies is providing considerable insight
into mechanisms of broad HIV-1 neutralization. Here we report an HIV-1 gp41 membrane-
proximal external region (MPER)-specific antibody, named 10E8, which neutralizes∼ 98%
of tested viruses. An analysis of sera from 78 healthy HIV-1-infected donors demonstrated
that 27% contained MPER-specific antibodies and 8% contained 10E8-like specificities. In
contrast to other neutralizing MPER antibodies, 10E8 did not bind phospholipids, was not …
Abstract
Characterization of human monoclonal antibodies is providing considerable insight into mechanisms of broad HIV-1 neutralization. Here we report an HIV-1 gp41 membrane-proximal external region (MPER)-specific antibody, named 10E8, which neutralizes ∼98% of tested viruses. An analysis of sera from 78 healthy HIV-1-infected donors demonstrated that 27% contained MPER-specific antibodies and 8% contained 10E8-like specificities. In contrast to other neutralizing MPER antibodies, 10E8 did not bind phospholipids, was not autoreactive, and bound cell-surface envelope. The structure of 10E8 in complex with the complete MPER revealed a site of vulnerability comprising a narrow stretch of highly conserved gp41-hydrophobic residues and a critical arginine or lysine just before the transmembrane region. Analysis of resistant HIV-1 variants confirmed the importance of these residues for neutralization. The highly conserved MPER is a target of potent, non-self-reactive neutralizing antibodies, suggesting that HIV-1 vaccines should aim to induce antibodies to this region of HIV-1 envelope glycoprotein.
nature.com